耳介迷走神経刺激装置の市場：装置タイプ、用途、エンドユーザー、流通チャネル別-2025-2030年の世界予測

耳介迷走神経刺激装置市場は、2023年に3億6,987万米ドルと評価され、2024年には3億9,256万米ドルに達すると予測され、CAGR 5.94％で成長し、2030年には5億5,421万米ドルに達すると予測されています。

耳介迷走神経刺激（aVNS）装置は、耳の外側にある迷走神経に焦点を当てた神経調節療法における重要な進歩です。これらの機器は、迷走神経の耳介枝を刺激するように設計された携帯可能で非侵襲的な機器として定義され、てんかん、うつ病、慢性疼痛など多くの健康状態に治療効果をもたらします。aVNS装置の必要性は、医薬品に関連する副作用を軽減できる非薬物治療の選択肢を提供できる可能性によって強調されています。これらの装置は、ヘルスケア産業、特に神経学と精神医学に主に応用され、病院、神経科クリニック、在宅療法を求める個人患者などのエンドユーザーにサービスを提供しています。市場成長の原動力となっているのは、神経疾患の増加、低侵襲治療への嗜好の高まり、規制認可の増加です。最新のビジネスチャンスは、メタボリックシンドロームやストレス関連疾患など、応用分野の多様化に向けた研究開発の拡大にあります。こうした機会を捉えるために、企業は機器の有効性と安全性を検証するための臨床試験やヘルスケアプロバイダーとの強力な連携に注力すべきです。しかし、市場拡大の妨げとなっているのは、高額な機器コスト、厳しい規制の枠組み、潜在的なユーザーや医療従事者の認知度の低さといった課題です。aVNS装置の技術革新は、コスト削減、ユーザーインターフェースの強化、ウェアラブル技術の統合を目標とし、装置へのアクセス性と利便性を向上させる必要があります。さらに、ハイテク企業との提携は、パーソナライズされた治療オプションのために人工知能と機械学習を統合することで、技術革新に拍車をかけることができます。市場のペースが速いため、継続的なモニタリングと、変化する規制や技術の進歩への適応が求められます。ヘルスケアとテクノロジーの交差点に位置し、カスタマイズされた患者ケアソリューションに重点を置く企業は、aVNS機器に対する需要の進化を利用する態勢を整えています。

市場力学：急速に進化する耳介迷走神経刺激装置市場の主要市場インサイトを公開

耳介迷走神経刺激装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 効果的な神経調節療法を必要とする慢性疾患の増加
  • 医療機器イノベーションのための研究開発投資の増加
  • 医療従事者および患者における神経刺激療法に対する認識と受容の高まり
  • 迷走神経刺激装置の採用を促進する低侵襲技術の進歩
• 市場抑制要因
  • 市場浸透を阻む耳介迷走神経刺激装置の高コスト
• 市場機会
  • 高度な耳介迷走神経刺激ソリューションを必要とする慢性疾患の有病率の増加
  • 耳介迷走神経刺激を含む非薬物療法の採用を促進する高齢化人口の拡大
  • メンタルヘルスに対する意識の高まりが耳介迷走神経刺激装置の需要を促進
• 市場の課題
  • 限られた臨床エビデンスがヘルスケア専門家の信頼性と受容性に影響

ポーターの5つの力：耳介迷走神経刺激装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：耳介迷走神経刺激装置市場における外部からの影響の把握

外部マクロ環境要因は、耳介迷走神経刺激装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析耳介迷走神経刺激装置市場における競合情勢の把握

耳介迷走神経刺激装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス耳介迷走神経刺激装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、耳介迷走神経刺激装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨耳介迷走神経刺激装置市場における成功への道筋を描く

耳介迷走神経刺激装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 効果的な神経調節療法を必要とする慢性疾患の増加
    • 医療機器の革新に向けた研究開発への投資の増加
    • ヘルスケア従事者と患者の間で神経刺激療法に対する認識と受容が高まっている
    • 低侵襲技術の進歩により迷走神経刺激装置の採用が促進される
  • 抑制要因
    • 耳介迷走神経刺激装置のコストが高いため、広範な市場浸透が阻害されている
  • 機会
    • 高度な耳介迷走神経刺激ソリューションを必要とする慢性疾患の増加
    • 高齢化人口の増加により、耳介迷走神経刺激療法などの非薬物療法の導入が進む
    • メンタルヘルスに関する意識の高まりが耳介迷走神経刺激装置の需要を押し上げている
  • 課題
    • 限られた臨床的証拠がヘルスケア専門家の信頼性と受容に影響を与える
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 耳介迷走神経刺激装置の市場デバイスタイプ別

• 外部デバイス
  • 電極
  • パワーユニット
• 埋め込み型デバイス
  • バイオセンサー

第7章 耳介迷走神経刺激装置の市場：用途別

• うつ
• てんかん
• 疼痛管理
  • 慢性疼痛
  • 片頭痛
• 耳鳴り

第8章 耳介迷走神経刺激装置の市場：エンドユーザー別

• ホームケア設定
• 病院
  • 入院患者
  • 外来患者

第9章 耳介迷走神経刺激装置の市場：流通チャネル別

• 直接販売
• 販売代理店
• オンライン小売

第10章 南北アメリカの耳介迷走神経刺激装置の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の耳介迷走神経刺激装置の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの耳介迷走神経刺激装置の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Bioness Inc.
• 2. ElectroCore, Inc.
• 3. LivaNova PLC
• 4. Medtronic plc
• 5. MicroTransponder Inc.
• 6. Nervana LLC
• 7. NeuroPace, Inc.
• 8. Neuros Medical, Inc.
• 9. NeuroSigma, Inc.
• 10. parasym Limited
• 11. ReShape Lifesciences Inc.
• 12. SetPoint Medical
• 13. Soterix Medical Inc.
• 14. tVNS Technologies GmbH

LIST OF FIGURES

• FIGURE 1. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY ELECTRODES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY POWER UNITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY TINNITUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IN-PATIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY OUT-PATIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 63. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 65. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 105. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 107. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 110. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 113. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 115. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 121. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 129. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 137. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 142. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 145. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 153. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 167. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 169. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 177. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 180. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 182. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 185. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 191. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 197. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 198. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 200. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 202. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 205. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 206. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 207. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 210. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 214. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 216. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 218. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 222. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 226. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 229. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 230. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 231. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 234. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 238. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 239. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 240. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 242. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 245. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 246. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 247. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 248. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 249. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 250. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 251. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 252. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 253. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 254. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 255. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 258. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 261. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 262. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 263. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 264. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 266. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 267. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 269. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 270. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 272. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 274. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 277. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 278. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 279. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
• TABLE 280. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MA

The Auricular Vagus Nerve Stimulation Devices Market was valued at USD 369.87 million in 2023, expected to reach USD 392.56 million in 2024, and is projected to grow at a CAGR of 5.94%, to USD 554.21 million by 2030.

Auricular Vagus Nerve Stimulation (aVNS) devices represent a significant advancement in neuromodulation therapies, focusing on the external vagus nerve located in the ear. These devices encompass a scope that includes definition as portable and non-invasive instruments designed to stimulate the auricular branch of the vagus nerve, providing therapeutic benefits for a multitude of health conditions like epilepsy, depression, and chronic pain. The necessity of aVNS devices is underscored by their potential to offer non-drug treatment alternatives that can reduce side effects associated with pharmaceuticals. These devices are predominantly applied in the healthcare industry, particularly in neurology and psychiatry, serving end-users such as hospitals, neurological clinics, and individual patients seeking home-based therapies. Market growth is powered by rising incidences of neurological disorders, escalating preference for minimally invasive treatments, and increasing regulatory approvals. The latest opportunities lie in expanding research and development efforts to diversify application areas, such as metabolic syndrome and stress-related ailments. To seize these opportunities, businesses should focus on clinical trials and strong collaborations with healthcare providers to validate device efficacy and safety. However, market expansion is hindered by challenges like high device costs, stringent regulatory frameworks, and a paucity of awareness among potential users and healthcare practitioners. Innovation in aVNS devices should target cost reduction, enhancing user interface, and integrating wearable technology to improve device accessibility and convenience. Moreover, partnerships with tech firms can spur innovation by integrating artificial intelligence and machine learning for personalized treatment options. The market's fast-paced nature demands continuous monitoring and adaptation to changing regulations and technological advancements. Businesses positioning themselves at the intersection of healthcare and technology, with an emphasis on customized patient care solutions, are poised to capitalize on the evolving demand for aVNS devices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Auricular Vagus Nerve Stimulation Devices Market

The Auricular Vagus Nerve Stimulation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases requiring effective neuromodulation therapies
  • Growing investments in research and development for medical device innovation
  • Rising awareness and acceptance of neurostimulation therapies among healthcare professionals and patients
  • Advancements in minimally invasive techniques enhancing the adoption of vagus nerve stimulation devices
• Market Restraints
  • High costs of auricular vagus nerve stimulation devices deterring widespread market penetration
• Market Opportunities
  • Increasing prevalence of chronic diseases demanding advanced auricular vagus nerve stimulation solutions
  • Expanding aging population driving adoption of non-pharmacological therapies including auricular vagus nerve stimulation
  • Rising awareness about mental health pushing demand for auricular vagus nerve stimulation devices
• Market Challenges
  • Limited clinical evidence affecting the credibility and acceptance among healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Auricular Vagus Nerve Stimulation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Auricular Vagus Nerve Stimulation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Auricular Vagus Nerve Stimulation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Auricular Vagus Nerve Stimulation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Auricular Vagus Nerve Stimulation Devices Market

A detailed market share analysis in the Auricular Vagus Nerve Stimulation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Auricular Vagus Nerve Stimulation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Auricular Vagus Nerve Stimulation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Auricular Vagus Nerve Stimulation Devices Market

A strategic analysis of the Auricular Vagus Nerve Stimulation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auricular Vagus Nerve Stimulation Devices Market, highlighting leading vendors and their innovative profiles. These include Bioness Inc., ElectroCore, Inc., LivaNova PLC, Medtronic plc, MicroTransponder Inc., Nervana LLC, NeuroPace, Inc., Neuros Medical, Inc., NeuroSigma, Inc., parasym Limited, ReShape Lifesciences Inc., SetPoint Medical, Soterix Medical Inc., and tVNS Technologies GmbH.

Market Segmentation & Coverage

This research report categorizes the Auricular Vagus Nerve Stimulation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device Type, market is studied across External Devices and Implantable Devices. The External Devices is further studied across Electrodes and Power Units. The Implantable Devices is further studied across Biosensors.
• Based on Application, market is studied across Depression, Epilepsy, Pain Management, and Tinnitus. The Pain Management is further studied across Chronic Pain and Migraine.
• Based on End User, market is studied across Homecare Settings and Hospitals. The Hospitals is further studied across In-Patient and Out-Patient.
• Based on Distribution Channel, market is studied across Direct Sales, Distributors, and Online Retail.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases requiring effective neuromodulation therapies
    • 5.1.1.2. Growing investments in research and development for medical device innovation
    • 5.1.1.3. Rising awareness and acceptance of neurostimulation therapies among healthcare professionals and patients
    • 5.1.1.4. Advancements in minimally invasive techniques enhancing the adoption of vagus nerve stimulation devices
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of auricular vagus nerve stimulation devices deterring widespread market penetration
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing prevalence of chronic diseases demanding advanced auricular vagus nerve stimulation solutions
    • 5.1.3.2. Expanding aging population driving adoption of non-pharmacological therapies including auricular vagus nerve stimulation
    • 5.1.3.3. Rising awareness about mental health pushing demand for auricular vagus nerve stimulation devices
  • 5.1.4. Challenges
    • 5.1.4.1. Limited clinical evidence affecting the credibility and acceptance among healthcare professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Auricular Vagus Nerve Stimulation Devices Market, by Device Type

• 6.1. Introduction
• 6.2. External Devices
  • 6.2.1. Electrodes
  • 6.2.2. Power Units
• 6.3. Implantable Devices
  • 6.3.1. Biosensors

7. Auricular Vagus Nerve Stimulation Devices Market, by Application

• 7.1. Introduction
• 7.2. Depression
• 7.3. Epilepsy
• 7.4. Pain Management
  • 7.4.1. Chronic Pain
  • 7.4.2. Migraine
• 7.5. Tinnitus

8. Auricular Vagus Nerve Stimulation Devices Market, by End User

• 8.1. Introduction
• 8.2. Homecare Settings
• 8.3. Hospitals
  • 8.3.1. In-Patient
  • 8.3.2. Out-Patient

9. Auricular Vagus Nerve Stimulation Devices Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Direct Sales
• 9.3. Distributors
• 9.4. Online Retail

10. Americas Auricular Vagus Nerve Stimulation Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Auricular Vagus Nerve Stimulation Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bioness Inc.
• 2. ElectroCore, Inc.
• 3. LivaNova PLC
• 4. Medtronic plc
• 5. MicroTransponder Inc.
• 6. Nervana LLC
• 7. NeuroPace, Inc.
• 8. Neuros Medical, Inc.
• 9. NeuroSigma, Inc.
• 10. parasym Limited
• 11. ReShape Lifesciences Inc.
• 12. SetPoint Medical
• 13. Soterix Medical Inc.
• 14. tVNS Technologies GmbH